Skeletal muscle atrophy: From mechanisms to treatments
L Yin, N Li, W Jia, N Wang, M Liang, X Yang… - Pharmacological …, 2021 - Elsevier
Skeletal muscle is a crucial tissue for movement, gestural assistance, metabolic
homeostasis, and thermogenesis. It makes up approximately 40% of the total body weight …
homeostasis, and thermogenesis. It makes up approximately 40% of the total body weight …
A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease
E Marty, Y Liu, A Samuel, O Or, J Lane - Bone, 2017 - Elsevier
Sarcopenia is defined as an age associated decline in skeletal muscle mass. The
pathophysiology of sarcopenia is multifactorial, with decreased caloric intake, muscle fiber …
pathophysiology of sarcopenia is multifactorial, with decreased caloric intake, muscle fiber …
[HTML][HTML] Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force
M Aapro, J Arends, F Bozzetti, K Fearon… - Annals of …, 2014 - Elsevier
Background Weight loss and cachexia are common, reduce tolerance of cancer treatment
and the likelihood of response, and independently predict poor outcome. Methods A group …
and the likelihood of response, and independently predict poor outcome. Methods A group …
Sarcopenia in the elderly: basic and clinical issues
C Wang, L Bai - Geriatrics & gerontology international, 2012 - Wiley Online Library
The original definition of sarcopenia refers to the age‐related loss of muscle mass. The
literature suggests that the prevalence of sarcopenia in 60‐to 70‐year‐olds is in the range of …
literature suggests that the prevalence of sarcopenia in 60‐to 70‐year‐olds is in the range of …
Current and future pharmacologic treatment of sarcopenia
Sarcopenia is a complex multifactorial condition that can by treated with multimodal
approaches. No pharmacologic agent to prevent or treat sarcopenia has proven to be as …
approaches. No pharmacologic agent to prevent or treat sarcopenia has proven to be as …
Metabolism and the heart: an overview of muscle, fat, and bone metabolism in heart failure
G Loncar, S Fülster, S von Haehling… - International journal of …, 2013 - Elsevier
PURPOSE OF REVIEW: To review original research studies and reviews that present data
on changes of body compartments and its mutual cross-talk with respect to the failing heart …
on changes of body compartments and its mutual cross-talk with respect to the failing heart …
[HTML][HTML] Heart failure-induced cachexia
Pacientes com insuficiência cardíaca frequentemente desenvolvem estado de caquexia,
que constitui fator independente de redução da sobrevida. Caquexia pode ser …
que constitui fator independente de redução da sobrevida. Caquexia pode ser …
Prevalence and importance of comorbidities in patients with heart failure
FK Triposkiadis, J Skoularigis - Current heart failure reports, 2012 - Springer
Heart failure (HF), being a disease of the elderly, is associated with several noncardiac
comorbidities, defined as chronic conditions coexisting with HF that play an integral role in …
comorbidities, defined as chronic conditions coexisting with HF that play an integral role in …
A practical guide for the stabilization of acylghrelin in human blood collections
M Blatnik, CI Soderstrom - Clinical endocrinology, 2011 - Wiley Online Library
Objective and methods To better understand acylghrelin plasma stability, human synthetic
acylghrelin was spiked into plasma and tracked by liquid chromatography tandem mass …
acylghrelin was spiked into plasma and tracked by liquid chromatography tandem mass …